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Summary
The objective of this study was to assess the validity and performance of the Arabic and
Turkish versions of the COPD Assessment Test (CAT) for evaluating the severity and impact
of COPD symptoms. The data were obtained from the BREATHE study in the Middle East and
North Africa region, a large general population survey of COPD conducted in ten countries
of the region (Algeria, Egypt, Jordan, Lebanon, Morocco, Saudi Arabia, Syria, Tunisia, Turkey
and United Arab Emirates), using a standardised methodology. A total of 62,086 subjects
were screened, of whom a random sample of 5,681 subjects were administered the CAT
by telephone. 5,639 evaluable questionnaires were recovered, representing a completion
rate of 99%. In addition, the CAT was administered to an additional 833 subjects fulﬁlling
the epidemiological diagnostic criteria for COPD. Mean scores in the general population
were 6.99±6.91 for the Arabic version and 9.88±9.04 for the Turkish version. In patients
with COPD, mean scores were 16.2±9.1 and 20.9±10.2 respectively. Scores were consistently
higher in smokers than in non-smokers. In the general population, the proportion of
respondents fulﬁlling criteria for COPD rose with higher CAT scores, and particularly above
the 80th percentile, where 63% of COPD cases were to be found. This suggests that the
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CAT may be useful as a case-ﬁnding tool in the general population. In the COPD population,
healthcare resource consumption rose linearly with CAT score above a threshold score of
twenty, arguing in favour of the good criterion validity of the CAT. The internal consistency
of the CAT was high (Cronbach’s a 0.85 for the Arabic and 0.86 for the Turkish versions)
and the factorial structure was unidimensional. In conclusion, this study performed in Arabic
and Turkish speaking populations conﬁrms the utility and validity of the CAT as a simple
tool to collect data on the severity and impact of COPD symptoms, and suggests that it may
potentially be useful as a case-ﬁnding tool to identify people at risk for COPD in the general
population.
© 2012 Elsevier Ltd. All rights reserved.
Introduction
Chronic obstructive pulmonary disease (COPD) is a chronic
progressive and invalidating respiratory condition with a
ﬂuctuating course characterised by irreversible airway
limitation. According to the World Health Organization’s
Global Burden of Disease Report (2004 update),1 COPD was
the fourth leading cause of death worldwide and ranks
thirteenth in terms of years lost due to disability. Nonethe-
less, it remains an illness that is often underdiagnosed
and frequently inadequately treated.2 Optimal treatment
requires careful monitoring of pulmonary function and
symptom course so that medication can be adapted over
time. In the most recent version of the Global Strategy for
Diagnosis, Management, and Prevention of COPD published
by the Global Initiative for Chronic Obstructive Lung
Disease (GOLD),3 it is recommended to stratify patients by
exacerbation risk and by symptom severity, and to use this
stratiﬁcation to choose the most appropriate treatment.
Information on the severity of symptoms and their impact
on patients’ lives can readily be captured using patient-
completed questionnaires,4 and a number of these have
been developed for use in COPD and have been psychomet-
rically validated. These include the St George’s Respiratory
Questionnaire (SGRQ),5 the Chronic Respiratory Question-
naire (CRQ),6 the Clinical COPD Questionnaire (CCQ)7 and,
most recently, the COPD Assessment Test (CAT).8
The CAT was developed using Item Response Theory with
the objective of creating a short assessment tool that would
be rapid and easy to complete whilst at the same time having
optimal measurement properties and discriminatory power
for determining the impact of COPD. It is an eight-item
questionnaire covering symptoms (cough, phlegm on chest
and chest tightness) and impact of symptoms (walking up
gradients, activities at home, going out, sleep and energy)
which is straightforward and rapid to complete. The 2011
GOLD guidelines recommend the CAT as an appropriate tool
with which to assess symptom severity in COPD. The original
English version has been translated into many languages
worldwide in addition to the German, French, Italian,
Spanish and Dutch versions used for its validation.9
We have recently performed a large epidemiological
survey of subjects presenting COPD-related symptoms in
the general populations of eleven countries in the Middle
East and North Africa (MENA) region using a standardised
methodology, the BREATHE study.10 The study collected in-
formation on risk factors, disease history, clinical symptoms,
impact on daily life, disease management and healthcare
resource consumption. It also provided an opportunity to
evaluate the CAT for measuring the impact of COPD in a non-
European context. The CAT was administered to a randomly
selected sample from the BREATHE study population by
telephone interview. This paper provides a description of the
information collected and an initial psychometric evaluation
of the Arabic and Turkish language versions of the CAT.
Methods
The BREATHE study was a cross-sectional epidemiological
survey of COPD conducted in 11 countries in the region
(Algeria, Egypt, Jordan, Lebanon, Morocco, Pakistan,
Saudi Arabia, Syria, Tunisia, Turkey and UAE) between
June 2010 and December 2011. A detailed description of
the methodology used in the study can be found in another
article in this supplement.10 The present article presents
the data obtained on impact of COPD using the CAT. This
chapter of the BREATHE study was not implemented in
Pakistan.
Study sample
A general population sample of 10,000 subjects in each
country or zone was generated from random telephone
numbers. All subjects (males or females) aged 40 years
who agreed to participate in the study were eligible and
were proposed a structured telephone interview. Subjects
not domiciled in the country or zone in question, or those
of foreign origin resident in the country for <6 months at
the time of the study were excluded, as were subjects with
comorbid mental illness.
Data collection
When initial telephone contact with each subject was
established, the interviewer explained the goal of the study
and the next steps. Subjects who agreed to participate
in the study (the screening population) were invited to
respond to a screening questionnaire that collected data
on demographics, respiratory symptoms and smoking habits.
Those subjects fulﬁlling two criteria for an ‘epidemiological’
deﬁnition of COPD were invited to respond to a second,
more detailed questionnaire. These criteria were ﬁrstly
a previous diagnosis of COPD, emphysema or chronic
bronchitis, or presenting with symptoms that fulﬁlled the
deﬁnition of chronic bronchitis or dyspnoea; secondly
a lifetime smoking exposure of 10 pack·years. This
‘COPD population’ completed a detailed questionnaire
on risk factors, comorbidities, disease history, clinical
symptoms, impact on daily life and disease management.
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Exacerbations
Information was also collected on disease exacerbations
in the previous six months. Since the BREATHE study
questionnaire addressed members of the general population
in non-medical terms, the number of exacerbations was not
explicitly documented and the presence of an exacerbation
was thus determined operationally. An exacerbation was
taken to have occurred in the previous six months if the
subject fulﬁlled any of the following criteria:
• Criterion 1: In the last 6 months, have you been told
by your physician that you have had worsening of your
“Respiratory Condition”? YES
• Criterion 2: In the last 6 months, have you been told by
your physician that you have had acute bronchitis? YES
• Criterion 3: In the last 6 months, what aspects of your
“Respiratory Condition” have worsened? (cough during the
daytime, cough during the night, phlegm, breathlessness
or shortness of breath and fatigue, ability to perform
regular activities) At least two symptoms cited
The COPD Assessment Test
The CAT is an eight-item questionnaire documenting the
subject’s evaluation of symptoms and their impact. Each
item is scored on a six-point scale ranging from 0 to 5
(Fig. 1) The total score can thus range from 0 to 40, with
higher scores representing greater impairment. As part of a
large international programme, the CAT has been translated
using a standardised and validated procedure into over ﬁfty
different languages available on the CAT website (http://
www.catestonline.org/). The Arabic and Turkish versions
used in this study were created as part of this programme.
The CAT questionnaire was administered to respondents
using the classical Arabic or Turkish version of the
questionnaire. These versions were linguistically validated
translations of the original British English questionnaire
generated by a process of translation, back-translation and
reconciliation in accordance with the ISPOR good research
practice guidelines for translations of patient-reported
outcome measures.11 The Arabic and Turkish language
versions of the CAT are provided in the Appendix. An
appropriately validated translation of the CAT into Urdu was
not available at the time when the study was initiated, and
this is the reason for which the CAT chapter of the BREATHE
study was not implemented in Pakistan.
The CAT was administered by telephone interview. In
each country, experienced interviewers attended one-
day training sessions organised by the clinical research
organisation in charge of implementation of the BREATHE
study. The objective of this training session was to ensure
that the CAT was administered in a standardised way across
the study and to minimise potential bias due to the interview
technique. The interviewers were directed to read the
instructions at the top of the questionnaire and then read
each question one by one. If the interviewee had queries
about how to respond, the interviewers were instructed
not to provide any additional information and were only
permitted to repeat the question.
The CAT questionnaire was completed by two groups of
subjects. The ﬁrst group consisted of a random sample of
5,800 subjects of the ‘screening population’ interviewed
(representing 10% of this population who spoke Arabic or
Turkish), who were invited to complete the CAT at the end of
the screening questionnaire; this group is referred to as the
‘General CAT population’. The second group consisted of all
subjects in the ‘COPD CAT population’, who completed the
CAT at the same time as the detailed COPD questionnaire.
Since certain individuals in the general CAT population
fulﬁlled the criteria for COPD, the general CAT population
and the COPD CAT population inevitably overlap.
Psychometric evaluation of the CAT questionnaire
Evaluation of the psychometric properties of the CAT ques-
tionnaire was carried out independently for respondents
using the Arabic and Turkish versions of the questionnaire.
The mean score, standard deviation, median, and
percentile distribution were calculated for each language
version of the CAT. The internal consistency of the
questionnaire was analysed using Cronbach’s a coefﬁcient.
This analysis was only performed for subjects with nomissing
data for any item in the questionnaire. For each item,
the correlation with all other items was calculated using
a Spearman rank correlation coefﬁcient. Conventionally,
a coefﬁcient >0.60 is considered to indicate a strong
correlation and a coefﬁcient >0.80 a very strong correlation.
The factorial structure of the CAT was explored using
principal component analysis with Varimax rotation and the
results displayed as a two-dimensional factorial map.
The discriminative validity of the CAT was assessed
by investigating the capacity of the questionnaire to
differentiate between patients with and without COPD.
Mean CAT scores and number of subjects by CAT category
(low impact: score10; medium impact: score 11 to 20; high
to very high impact: score >20) were calculated for subjects
with COPD (fulﬁlling both the diagnosis/symptoms criterion
and the smoking criterion of the epidemiological deﬁnition
of COPD), subjects with possible COPD (fulﬁlling one or other
of these two criteria, but not both) and non-COPD subjects
(fulﬁlling neither criterion). Criterion validity was evaluated
by assessing the relationship between CAT score and smoking
status, healthcare resource utilisation and exacerbations.
Statistical analysis
Regarding missing data, if more than one item was not
completed, the questionnaire was considered unusable. If
the score was missing for only one item, then this was
replaced by the mean value of the remaining seven items.
Two study populations were analysed. These are the
General CAT population and the COPD CAT population (as
deﬁned above). Analyses in the General CAT population
were performed separately for Arabic-speaking and Turkish-
speaking respondents. Analyses in the COPD CAT population
were performed for all respondents combined. For the
determination of the factorial structure and the internal
consistency of the CAT, the General CAT population and the
COPD CAT population were combined and subjects for whom
any items of the CAT were missing were excluded.
Comparisons were performed using non-parametric tests
(Mann Whitney test for comparing two groups; Kruskal
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Name: Today's Date:
Example: I am very happy I am sad
I never cough I cough all the time
I have no phlegm (mucus) in
my chest at all
My chest is full of phlegm
(mucus)
My chest does not feel tight at
all
My chest feels very tight
When I walk up a hill or one
ﬂight of stairs I am not
breathless
When I walk up a hill or one
ﬂight of stairs I am very
breathless
I am not limited doing any
activities at home
I am very limited doing
activities at home
I am conﬁdent leaving my
home despite my lung
condition
I am not at all conﬁdent leaving
my home because of my lung
condition
I sleep soundly
I don't sleep soundly because
of my lung condition
I have lots of energy I have no energy at all
How is your COPD? Take the COPD Assessment Test (CAT)
This questionnaire will help you and your healthcare professional measure the impact COPD (Chronic Obstructive Pulmonary Disease) is having on your
wellbeing and daily life. Your answers and test score, can be used by you and your healthcare professional to help improve themanagement of your COPD and
get the greatest beneﬁt from treatment.
SCORE
COPD Assessment Test and CAT logo is a trade mark of the GlaxoSmithKline
group of companies.
©2009 GlaxoSmithKline group of companies. All rights reserved.
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Figure 1. COPD Assessment Test (CAT). Available online at http://www.catestonline.org/
Wallis test for more than two groups). All statistical tests
were two-sided, with an a-level of 0.05. Statistical analysis
was performed using SPSS software Version 17.
Results
Study populations
The total population screened in participating countries was
composed of 15,086 Turkish-speaking individuals and 42,625
Arabic-speaking individuals. Of this population, a subgroup
of 5,681 were randomised and invited to complete the
CAT, of whom 5,639 (99.3%) provided a valid questionnaire
(i.e. <1 item missing). These comprise the ‘General CAT
population’ (Fig. 2). The demographic features on the
General CAT population are presented in Table 1. It should
be noted that data for variables other than age and gender
are only available for the 205 subjects who completed
the detailed COPD questionnaire. In addition, all screened
patients who fulﬁlled the epidemiological case deﬁnition
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Eligible subjects
N = 58 431,
Arabic-speaking
N = 43 345,
‘COPD CAT populaon’ N = 1 035,
Met COPD criteria
N = 205
Not COPD
N = 5 434,
COPD criteria met
N = 1 901,
COPDcriteria unmet
N = 50 849,Completed CAT
‘ ’General CAT populaon
N = 5,639
Not proposed CAT
N = 52 750,
Completed CAT
N = 830
Performed CAT
N = 833
Proposed CAT
N = 5 681,
Screening populaon
N = 62 086,
Arabic: N = 4 220,
Turkish: N = 1 419,
Arabic: N = 806
Turkish: N = 229
Turkish-speaking
N = 15 086,
Urdu-speaking
N = 3 655,
Randomisaon
Performed CAT
N = 5 681,
Figure 2. Origin of CAT questionnaires.
of COPD were invited to complete the extensive COPD
questionnaire. These included 1,901 subjects who had not
been part of the group randomised to complete the CAT. Of
these, 833 (43.8%) agreed to participate and 830 provided
a valid CAT questionnaire. The latter, together with the
205 individuals who had been selected as part of the
‘General CAT population’ and who had also screened positive
for COPD, constitute the ‘COPD CAT population’ (Fig. 2).
In the ‘General CAT population’, 6,065 questionnaires were
completed in Arabic (74.8%) and 1,744 in Turkish (25.2%).
Completion of the CAT
For all subjects who accepted to complete the CAT, the
amount of missing data was low. All the Turkish versions
of the questionnaire were returned fully completed. Of
the 5,071 Arabic questionnaires received, 69 (1.4%) had
at least one item missing and 45 (0.9%) had more than
one item missing. The latter were considered unusable.
The extent of missing data was comparable for respondents
from the general population and from the COPD population.
Regarding the individual items, the extent of missing data
was highest (1.2%) for Item 5 (I am conﬁdent leaving my
home despite my lung condition ; for the other items, it was
less than one percent.
Analyses in the General CAT population
Description of CAT scores
The distributions of CAT scores in the General CAT
population are presented in Table 2 for the Arabic-speaking
subjects and in Table 3 for the Turkish-speaking subjects.
With respect to the Arabic version, the mean score was 6.99
and the median score 5, with 90% of subjects scoring
between 0 and 21 (inter-95 percentile range [I95%R]). Mean
and median scores were higher in women (7.78 and 6
respectively) than in men (6.15 and 4), and increased
slightly with age. For the Turkish version, the mean and
median scores were higher, 9.88 and 8 respectively, and the
spread of scores wider (I95%R: 0 to 28). This difference was
particularly marked for women, whose mean and median
scores were around four points higher than for women
responding to the Arabic version of the questionnaire.
Face validity smoking
Since the proportion of women who smoke is generally
higher in Turkey than in the Arabic-speaking countries, mean
CAT scores were compared between men and women ac-
cording to smoking status (Fig. 3). Scores were consistently
higher in smokers than in non-smokers irrespective of gender
and language in which the questionnaire was administered;
this difference was more pronounced in men than in
women. Mean CAT scores in Turkish-speaking women were
higher than in Arabic-speaking women for both smokers
and non-smokers. A two-way analysis of variance revealed
a signiﬁcant association between gender and CAT score
for both the Arabic-speaking and Turkish-speaking samples
(p < 0.0001), and a signiﬁcant association with smoking
status only for the Arabic-speaking subgroup (p = 0.0006).
Mean CAT scores were also compared by gender and
smoking status between the different participating Arabic-
speaking countries (Table 4). Relatively large differences
in mean scores were observed between countries, being
generally higher in Saudi Arabia, Lebanon and Egypt
and lower in the North African countries. Higher scores
were found consistently in women than in men and
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Table 2
Distribution of CAT scores in the General CAT population from Arabic-speaking respondents
CAT Score
percentile
Women
40 49 yrs
N = 1,107
50 59 yrs
N = 547
60 yrs
N = 412
Total
N = 2,066
Men
40 49 yrs
N = 1,051
50 59 yrs
N = 642
60 yrs
N = 461
Total
N = 2,154
Total
N = 4,220
5th 0 0 0 0 0 0 0 0 0
10th 0 0 0 0 0 0 0 0 0
20th 1 2 1 1 0 1 0 0 1
30th 3 3 3 3 2 2 2 2 2
40th 4 5 4 4 3 3 3 3 4
50th 6 6 6 6 4 4 5 4 5
60th 7 8 8 8 6 6 6 6 7
70th 10 10 11 10 8 7 9 8 9
80th 13 14 14 13 11 10 12 11 12
90th 18 18 20 18 15 14 16 15 17
95th 22 22 24 22 19 20 20 19 21
Mean±SD 7.51
±7.08
7.96
±6.96
8.17
±7.76
7.78
±7.20
6.04
±6.29
6.05
±6.61
6.58
±6.87
6.15
±6.49
6.99
±6.91
Table 3
Distribution of CAT scores in the General CAT population from Turkish-speaking respondents
CAT Score
percentile
Women
40 49 yrs
N = 339
50 59 yrs
N = 250
60 yrs
N = 270
Total
N = 859
Men
40 49 yrs
N = 177
50 59 yrs
N = 200
60 yrs
N = 183
Total
N = 560
Total
N = 1,419
5th 0 0 0 0 0 0 0 0 0
10th 0 0 0 0 0 0 0 0 0
20th 3 3 2 3 1 1 0 0 2
30th 5 5 5 5 2 3 1 2 4
40th 7 8 7 7 3 4 3 3 5
50th 9 11 10 10 5 5 5 5 8
60th 11 14 13 13 7 7 6 7 10
70th 15 16 15 15 10 10 9 10 13
80th 20 20 20 20 14 12 13 13 17
90th 25 25 26 25 18 17 19 18 23
95th 29 27 32 30 23 22 26 22 28
Mean
±SD
11.0
±9.15
12.0
±9.13
11.6
±10.1
11.5
±9.44
7.61
±8.14
7.43
±7.23
7.26
±8.06
7.43
±7.79
9.88
±9.04
in smokers than in non-smokers. In all countries, two-
way analysis of variance revealed signiﬁcant associations
between CAT score and gender (in countries where a
relatively low proportion of women smoke) or between
CAT score and smoking status (in countries where a relatively
high proportion of women smoke). It should be noted that
gender and smoking status were closely associated with each
other, which explains why either gender or smoking, but not
both, explained differences between subjects.
Discriminant validity
The distribution of subjects fulﬁlling the epidemiological
deﬁnition of COPD within the General CAT population was
evaluated as a function of the CAT score (Fig. 4). For
both the Arabic and Turkish versions, the proportion of
respondents fulﬁlling the epidemiological deﬁnition rose
with higher CAT scores. Below the 50th percentile, less than
3% of respondents fulﬁlled the deﬁnition of COPD, whereas
this proportion rose pronouncedly above the 80th percentile.
In the highest percentile (90 100%), around forty percent
of subjects overall fulﬁlled the deﬁnition. Even though
the absolute CAT score corresponding to each percentile
range differed between the Arabic and Turkish versions of
the questionnaire, the relationship between percentile CAT
score and the proportion of subjects fulﬁlling the case deﬁni-
tion was quite similar between the two language versions.
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Figure 3. Mean CAT scores as a function of gender and smoking status. Data are presented with their standard deviations. Open
columns: non-smokers; shaded columns: smokers.
Table 4
Mean CAT scores as a function of gender and smoking status in nine Arabic-speaking countries a
Algeria Egypt Jordan Lebanon Morocco Saudi
Arabia
Syria Tunisia UAE
Women
Non-smokers N = 146
4.24±4.75
N = 654
8.10±7.05
N = 197
5.54±6.92
N = 94
6.69±6.01
N = 151
8.15±6.75
N = 357
10.5±8.26
N = 105
6.53±6.77
N = 77
5.66±5.85
N = 129
6.57±6.49
Smokers None N = 49
10.1±7.60
N = 42
7.52±8.32
N = 88
8.41±5.72
N = 3
11.0±2.65
N = 28
12.8±8.79
N = 30
8.20±7.03
N = 1 N = 12
7.17±6.74
Men
Non-smokers N = 111
1.36±2.68
N = 145
5.26±5.09
N = 43
4.23±4.70
N = 34
4.71±4.33
N = 138
4.29±5.15
N = 398
6.41±6.17
N = 47
4.34±4.40
N = 77
5.94±5.93
N = 68
3.82±4.41
Smokers N = 146
2.82±4.59
N = 180
7.99±7.73
N = 50
8.84±7.73
N = 69
8.38±7.15
N = 105
7.70±7.96
N = 279
8.47±7.18
N = 82
7.60±5.99
N = 48
8.94±7.51
N = 46
6.52±6.24
2-way ANOVA p -values
Gender vs CAT <0.0001 0.0018 0.35 0.64 0.0005 <0.0001 0.53 0.11 0.0253
Smoking vs CAT 0.70 0.11 0.0007 0.0022 0.05 0.29 0.0147 0.0047 0.2535
a Probability values indicated in bold are signiﬁcant at the 0.05 threshold.
Mean CAT scores and distribution of CAT scores were also
compared between subjects fulﬁlling the epidemiological
deﬁnition of COPD (both symptoms/diagnosis criterion and
smoking criterion fulﬁlled), subjects assigned possible COPD
status (either symptoms/diagnosis criterion or smoking
criterion fulﬁlled) and subjects without COPD (neither symp-
toms/diagnosis criterion nor smoking criterion fulﬁlled).
Mean scores were lowest in the subjects without COPD
and highest in the COPD group, an approximately three-
fold difference which was observed for both language
versions (Table 5). Similarly, over half the subjects without
COPD scored less than 10 on the CAT, whereas 32% (Arabic
version) and 50% (Turkish version) of the COPD group scored
at least 20, corresponding to a high or very high impact of
disease (Table 5).
Analyses in the COPD CAT population
Description of CAT scores
In the COPD CAT population, the mean and median CAT
scores in Arabic-speaking subjects were 16.2 and 16
respectively (Table 6). Mean and median scores were
higher in women than in men, whereas there was no
clear relationship between CAT score and age group. For
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Figure 4. Proportion of subjects fulﬁlling the epidemiological deﬁnition for COPD as a function of CAT score. CAT scores are divided
into percentiles; the absolute CAT scores associated with each percentile range in each language version are listed
beside each percentile. Left-hand panel: Arabic version (N = 4,220; each decile represents 422 subjects); right-hand
panel: Turkish version (N = 1,419; each decile represents 142 subjects).
Table 5
Mean CAT scores and CAT score distribution as a function of COPD status
Non COPD Possible COPD COPD Signiﬁcance
Arabic version N=2,863 N=1,210 N=806
Mean score [95% conﬁdence interval] 5.40 [5.20 5.60] 9.60 [9.15 10.05] 16.16 [15.53 16.79] p < 0.0001
CAT score 0 10 (low impact ) 2,306 (80.5%) 689 (56.9%) 207 (25.7%) p < 0.0001
CAT score 10 20 (medium impact ) 503 (17.6%) 384 (31.7%) 339 (42.1%)
CAT score 20 40 (high to very high impact ) 54 (1.9%) 137 (11.3%) 260 (32.3%)
Turkish version N=872 N=489 N=229
Mean score [95% conﬁdence interval] 8.07 [7.56 8.58] 11.98 [11.09 12.87] 20.90 [19.58 22.23] p < 0.0001
CAT score 0 10 (low impact ) 564 (64.7%) 233 (47.6%) 36 (15.7%) p < 0.0001
CAT score 10 20 (medium impact ) 237 (27.2%) 161 (32.9%) 79 (34.5%)
CAT score 20 40 (high to very high impact ) 71 (8.1%) 95 (19.4%) 114 (49.8%)
Turkish-speaking subjects, themean andmedian scores were
20.9 and 20 respectively (Table 7). Again scores in women
were higher than scores in men, but this difference was less
marked than that observed in the General CAT population.
Criterion validity healthcare resource consumption
The utilisation of healthcare resources for respiratory
complaints in the previous year was evaluated as a function
of CAT score in the COPD CAT population (Fig. 5). Below a
CAT score of 20, the number of consultations was relatively
stable at around 175 consultations/100 subjects and the
number of hospitalisations and emergency room visits low
(around ten events/100 subjects in both cases). However,
above the CAT threshold of 20 points, all three types
of resource use rose steeply and relatively linearly with
increasing CAT score.
Criterion validity exacerbations
The proportion of patients in whom an exacerbation had
occurred in the previous six months was also determined as
a function of CAT score in the COPD CAT population (Fig. 6).
This proportion rose progressively with increasing CAT score,
reaching a value of 97.4% in the group of subjects in the
highest CAT score range (36 40).
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Table 6
Distribution of CAT scores in the COPD CAT population from Arabic-speaking respondents
CAT score
percentile
Women
40 49 yrs
N = 57
50 59 yrs
N = 47
60 yrs
N = 32
Total
N = 136
Men
40 49 yrs
N = 280
50 59 yrs
N = 209
60 yrs
N = 181
Total
N = 670
Total
N = 806
5th 2 2 0 2 2 2 2 2 2
10th 5 5 1 4 4 4 4 4 4
20th 12 8 6 8 9 7 7 8 8
30th 15 9 11 12 11 10 10 10 11
40th 18 12 14 15 13 11 13 13 13
50th 21 15 17 18 16 14 15 15 16
60th 23 19 22 21 18 17 17 17 18
70th 24 22 26 24 21 20 20 21 21
80th 28 26 31 28 25 23 24 24 25
90th 30 31 37 31 28 29 27 28 29
95th 31 34 39 35 30 34 32 31 32
Mean±SD 19.1
±9.0
16.5
±9.8
18.5
±12.3
18.0
±10.1
16.3
±8.6
15.3
±9.1
15.6
±8.8
15.8
±8.8
16.2
±9.1
Table 7
Distribution of CAT scores in the COPD CAT population from Turkish-speaking respondents
CAT score
percentile
Women
40 49 yrs
N = 48
50 59 yrs
N = 39
60 yrs
N = 20
Total
N = 107
Men
40 49 yrs
N = 32
50 59 yrs
N = 44
60 yrs
N = 46
Total
N = 122
Total
N = 229
5th 3 3 3 3 6 5 4 5 5
10th 7 7 6 7 10 7 7 8 7
20th 14 10 12 11 13 8 10 10 11
30th 19 12 16 16 17 12 12 13 14
40th 20 17 22 20 19 14 17 16 18
50th 24 20 27 23 21 17 21 20 20
60th 25 24 28 25 27 20 24 23 25
70th 28 26 31 28 28 23 27 27 27
80th 30 30 34 30 30 31 30 30 30
90th 33 38 37 35 31 35 36 35 35
95th 40 40 40 40 37 39 40 38 40
Mean±SD 22.2
±9.7
20.2
±10.8
23.5
±10.9
21.7
±10.3
21.8
±8.9
18.7
±10.3
20.5
±10.6
20.2
±10.1
20.9
±10.2
Analyses in the combined General CAT and COPD
CAT populations
Internal consistency and factorial analysis
These analyses were performed for 4,807 CAT questionnaires
in Arabic and 1,590 questionnaires in Turkish. The Cronbach
a coefﬁcient was 0.847 for the Arabic version of the
questionnaire and 0.858 for the Turkish version, indicating
a high degree of internal consistency in both cases.
Correlations between scores on the different items of the
CAT were moderate for both language versions of the
questionnaire (Table 8 and Table 9), and there was no
indication of clustering of particular items.
The factorial structure of the questionnaire was explored
using principal component analysis. This identiﬁed two
dimensions which explained 80.0% (Arabic version) and
91.7% (Turkish version) of the variance in the item scores.
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Figure 5. Healthcare resource consumption as a function of CAT score in the COPD CAT population. Open columns: consultations;
grey columns: hospitalisations; black columns: emergency room visits.
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Figure 6. Occurrence of exacerbations in the previous six months as a function of CAT score in the COPD CAT population.
Table 8
Spearman rank correlation coefﬁcients for the correlation between scores on different items of the Arabic version of the CAT
Item score Item score
Cough Phlegm Chest tightness Breathlessness Activities Going outdoors Sleep Energy
Cough 1
Phlegm 0.603 1
Chest tightness 0.495 0.551 1
Breathlessness 0.407 0.414 0.522 1
Activities 0.294 0.315 0.402 0.509 1
Going outdoors 0.304 0.323 0.387 0.372 0.389 1
Sleep 0.402 0.409 0.488 0.423 0.367 0.458 1
Energy 0.299 0.315 0.372 0.419 0.516 0.312 0.376 1
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Table 9
Spearman rank correlation coefﬁcients for the correlation between scores on different items of the Turkish version of the CAT
Item score Item score
Cough Phlegm Chest tightness Breathlessness Activities Going outdoors Sleep Energy
Cough 1
Phlegm 0.577 1
Chest tightness 0.517 0.596 1
Breathlessness 0.362 0.370 0.528 1
Activities 0.334 0.344 0.468 0.532 1
Going outdoors 0.365 0.399 0.502 0.414 0.469 1
Sleep 0.357 0.359 0.465 0.423 0.440 0.405 1
Energy 0.309 0.304 0.440 0.486 0.496 0.358 0.457 1
These were the only two dimensions which presented an
Eigenvalue >1. All items of the CAT loaded predominantly
onto the ﬁrst dimension (Eigenvalue of 3.91 for the Arabic
version and 4.08 for the Turkish version).
Discussion
The objective of this study was to collect data on
the severity of COPD symptoms using the Arabic and
Turkish language versions of the CAT and to evaluate its
psychometric properties in populations in the Middle East
and North Africa. This is the ﬁrst large-scale assessment of
the CAT in the general population for any language. The
study presented a number of other original features; for
example, the CAT was administered by telephone interview
rather than being ﬁlled in directly by the subject. In
addition, the CAT was also administered to subjects in the
general population who did not have COPD.
Although this is the ﬁrst time that the CAT has been used
in Turkish, a study using a slightly different Arabic version
performed in Saudi Arabia has recently been published.12
This pilot study in 45 patients with spirometrically-
ascertained COPD reported good interclass correlation
between the items and good test retest reproducibility.
The mean CAT score of the patients reported in that
study was 10.4, which is lower than the mean score (16.2)
identiﬁed for a much larger sample drawn from nine Arabic-
speaking countries in the present study.
The acceptability of the CAT appeared high, since all the
subjects in the General CAT population agreed to complete
it, and the number of unusable questionnaires was very
low. All Turkish respondents completed the CAT fully, as
was the case for 98.7% of Arabic-speaking respondents. This
high response rate may in part be attributable to the fact
that the CAT was administered by the interviewer over
the telephone, rather than completed independently by
respondents, but nonetheless it suggests that the questions
were clear and easy to understand. In the group of
subjects fulﬁlling the epidemiological deﬁnition of COPD,
the proportion of subjects who completed the CAT was
lower (44%). However, in this case, the CAT was administered
as part of a detailed interview containing over seventy
questions which lasted around forty-ﬁve minutes, in which
certain eligible subjects may not have been prepared to take
part.
In the General CAT population, the CAT score distribution
differed somewhat between the Arabic and Turkish version
of the questionnaire, with Turkish respondents tending
to score higher than Arabic-speaking respondents. This
difference was particularly striking for women. We have
no explanation for this observation, although it does not
seem to be a consequence of differences in smoking rates
between different countries. A difference between score
distributions was also observed in the COPD CAT population.
Nonetheless, the mean scores observed for both versions
(16.2 for the Arabic version and 20.9 for the Turkish version)
are relatively close to those observed for respondents in
the initial development of the CAT in patients with COPD
ascertained by spirometry in Europe,8 where mean scores
ranged from 16.0 in the Netherlands to 21.5 in Belgium.
The primary objective of the BREATHE study was to
identify the prevalence of COPD-related symptoms in
the general populations of eleven countries. This goal
necessitated making strategic choices about the most
appropriate methodology, in particular between home-
based interviews or systematic standardised spirometry.
The former method relies on respondent self-reporting
for identifying COPD cases, which may be less accurate
than spirometry, but can provide more complete coverage
of the population. Spirometry-based surveys have the
advantage of more precise case-ﬁnding, but may suffer from
suboptimal representativeness, and the number of subjects
that can be screened is limited. In the BREATHE study,
telephone interviews were chosen to collect data in order to
achieve a high response rate, a high sample size, adequate
generalisability and representativeness and to allow reliable
standardisation between countries. In order to optimise the
reliability of the diagnostic assignment in a non-medical
context, we used a simple standardised questionnaire which
had previously been validated in the Confronting COPD
surveys, in which it has been demonstrated to have high
sensitivity (92.0%) and speciﬁcity (72.4%) with respect to the
diagnosis of COPD by spirometry.13 Further information on
the reasons behind the choices made for the design of the
study, and for their implications for interpreting the data,
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is provided in the article describing the Methodology of the
study.10
An original feature of the BREATHE study was thus that
the CAT was administered to a random sample of subjects
aged 40 years drawn from the general population of
participating countries. This enabled the diagnostic capacity
of the CAT to be evaluated. The mean CAT scores in
subjects who fulﬁlled the epidemiological deﬁnition of COPD
used in the study were around three times higher than in
those who reported neither COPD symptoms nor cigarette
exposure over ten pack·years. Subjects who reported COPD
symptoms or cigarette exposure over ten pack·years, but
not both, presented intermediate CAT scores. In addition,
the proportion of subjects fulﬁlling the epidemiological
deﬁnition of COPD rose with increasing CAT score, with most
of the COPD cases being concentrated in the uppermost
thirty percentile of CAT scores, corresponding to CAT scores
above ~14. This suggests that the CAT may be useful for
case ﬁnding of COPD cases in the general population, which
could offer a simple and low-cost method to help improve
the diagnosis of COPD. Another recent study performed in
Canada also suggests that the CAT may be of value for
case-ﬁnding.14 Further work needs to be done to assess the
sensitivity, speciﬁcity and overall performance of the CAT in
this application.
The psychometric properties of the Arabic and Turkish
versions of the CAT were satisfactory, with a Cronbach
a coefﬁcient of 0.85; for comparison, the Cronbach
a coefﬁcient for the original English-language version of
the CAT was 0.88.8 The factorial structure showed that all
items loaded principally onto a single dimension. This was
expected, since the methodology used in developing the CAT
leads to a unidimensional structure. Mean CAT scores were
higher in smokers than in non-smokers, an observation that
has also been made using the SGRQ.15 For the Arabic version
of the questionnaire, the mean CAT scores also increased
somewhat with age. CAT scores in women were higher than
those in men, similar to many, if not most, patient-reported
outcome measures; however this may also reﬂect gender-
related differences in exposure to risk factors for respiratory
disease, such as smoke from biomass fuels used for cooking.
The criterion validity of the CAT is supported by the
observation in the COPD CAT population that subjects
with higher CAT scores were more likely to report recent
exacerbations, as deﬁned operationally in our study. That
deﬁnition has not been validated previously, however the
proportion of the COPD population reporting exacerbations
is similar to that reported in a previous large primary
care study of the CAT,16 and in which an association
between exacerbation rate and CAT score was also
observed. Furthermore, a strong association was observed
in the BREATHE study, reported elsewhere,17 between the
occurrence of exacerbations as deﬁned in the study and
hospitalisation and emergency room visits, arguing in favour
of the criterion validity of the deﬁnition used. Nonetheless,
it would be useful to compare the performance of this
deﬁnition against physician-ascertained exacerbations in a
future study. Further supporting the criterion validity of
the CAT, and as described in the article devoted to data
from the BREATHE study on burden of disease,18 mean
CAT scores were also strongly associated with perceived
disease severity in subjects fulﬁlling the epidemiological
deﬁnition of COPD.
Subjects with higher CAT scores were more likely to have
needed acute medical interventions. Indeed, hospitalisa-
tions and emergency visits were infrequent in subjects with
CAT scores under 20, but their use rose proportionally to
the CAT score for scores between 20 and 40. The CAT may
thus also be useful in community practice for identifying
those COPD patients who are at risk of acute medical
emergencies, and thus alert treating physicians that the
treatment strategy may need to be revised. In this context,
the CAT may be useful as a communication tool to facilitate
patient physician dialogue and to optimise the involvement
of patients in managing their disease.
In conclusion, this study performed in Arabic- and Turkish-
speaking populations conﬁrms the utility and validity of the
CAT as a simple tool to collect data on the severity of COPD
symptoms and their impact. The psychometric properties of
the questionnaire are satisfactory and consistent with those
previously reported in European populations. The CAT may
also have a potential role as a case-ﬁnding tool to identify
people at risk for COPD in the general population and has
application in routine clinical practice of patients at greater
risk of exacerbation and hospitalisation.
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Appendix. Arabic and Turkish versions of the
CAT questionnaire
Arabic version
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